Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.
| Current Price | ₹123.00 |
|---|---|
| Market Cap | ₹93 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 22.9 |
| Return on Equity | 6.86% |
| 52-Week Range | ₹69.70 – ₹135.25 |
| Beta (1Y) | 0.49 |
1. Manufacture and Sale of Active Pharmaceutical Ingredients (API) and its intermediates-100%
Godavari Drugs Ltd. is trading at ₹123.00, with a market capitalisation of ₹93 Cr.
Godavari Drugs Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Godavari Drugs Ltd. has a P/E of 22.9 and a return on equity of 6.86%.